rs545954490

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_001267550.2(TTN):​c.76654C>T​(p.Arg25552*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000372 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

TTN
NM_001267550.2 stop_gained

Scores

4
2
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 5.81

Publications

5 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 2-178569478-G-A is Pathogenic according to our data. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178569478-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 404828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.76654C>T p.Arg25552* stop_gained Exon 326 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.76654C>T p.Arg25552* stop_gained Exon 326 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152026
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000403
AC:
1
AN:
247864
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000561
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1460496
Hom.:
0
Cov.:
40
AF XY:
0.00000551
AC XY:
4
AN XY:
726398
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33434
American (AMR)
AF:
0.00
AC:
0
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86178
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53348
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111132
Other (OTH)
AF:
0.00
AC:
0
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152144
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41536
American (AMR)
AF:
0.00
AC:
0
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67976
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000828
AC:
1

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg25552*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (rs545954490, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with clinical features of dilated cardiomyopathy (PMID: 30847666; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg22984*. ClinVar contains an entry for this variant (Variation ID: 404828). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). For these reasons, this variant has been classified as Pathogenic. -

Dilated cardiomyopathy 1G Pathogenic:1
Feb 02, 2022
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is known mechanism of disease in this gene. In addition, dominant-negative is also a suggested mechanism. (PMID: 25589632). (I) 0108 - This gene is associated with both recessive and dominant disease (OMIM). (I) 0112 - The condition associated with this gene has incomplete penetrance. Variants in this gene that result in a premature truncating codon (PTC) are known to have reduced penetrance in DCM (PMID: 25589632). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (2 heterozygotes, 0 homozygotes). (SP) 0600 - Variant is located in the annotated C-terminal A-band and the exon has a PSI score of 100 (PMID: 25589632). (I) 0703 - Other NMD predicted variants comparable to the one identified in this case have moderate previous evidence for pathogenicity (ClinVar). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as likely pathogenic in individuals with cardiomyopathy (ClinVar, PMID: 30847666). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
Nov 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Dec 27, 2018
Blueprint Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Pathogenic:1
Apr 21, 2025
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R16487* variant (also known as c.49459C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 49459. This changes the amino acid from an arginine to a stop codon within coding exon 153. This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (also referred to as NM_133378.4:c.68950C>T, p.Arg22984* and NM_001256850.1:c.71731C>T, p.Arg23911Ter) has been detected in an individual with unspecified cardiomyopathy, and in an individual with idiopathic dilated cardiomyopathy (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309; Trachoo O et al. PLoS One. 2022 Sep;17(9):e0267770). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This variant is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53; Akhtar MM et al. Circ Heart Fail, 2020 Oct;13:e006832; Massier M et al. Clin Genet, 2025 Jan). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.49
D
BayesDel_noAF
Pathogenic
0.63
CADD
Pathogenic
65
DANN
Uncertain
0.97
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Uncertain
0.94
D
PhyloP100
5.8
Vest4
0.94
GERP RS
4.7
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs545954490; hg19: chr2-179434205; COSMIC: COSV59876512; API